- £2.16bn
- £2.75bn
- $3.72bn
- 57
- 87
- 60
- 81
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,585 | 2,414 | 3,479 | 5,390 | 3,715 |
Cost of Revenue | |||||
Gross Profit | 1,242 | 566 | 1,026 | 2,545 | 1,358 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,130 | 3,101 | 2,839 | 2,849 | 2,802 |
Operating Profit | 455 | -687 | 640 | 2,541 | 913 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 103 | -978 | 315 | 2,462 | 597 |
Provision for Income Taxes | |||||
Net Income After Taxes | 155 | -778 | 101 | 1,478 | 32 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 164 | -778 | 101 | 8.2 | 32 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 164 | -778 | 101 | 8.2 | 32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.97 | 0.344 | 0.393 | 1.5 | 0.232 |
Dividends per Share |